Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $107,125 | 36 | 98.0% |
| Travel and Lodging | $1,800 | 8 | 1.6% |
| Food and Beverage | $368.96 | 13 | 0.3% |
| Education | $21.52 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $71,735 | 17 | $0 (2023) |
| Boehringer Ingelheim International GmbH | $15,825 | 2 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $10,430 | 14 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $6,790 | 15 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $4,356 | 7 | $0 (2019) |
| Penumbra, Inc. | $179.12 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $84,360 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($68,535) |
| 2022 | $3,379 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,200) |
| 2021 | $10,430 | 14 | Merck Sharp & Dohme Corporation ($10,430) |
| 2019 | $11,146 | 22 | Otsuka America Pharmaceutical, Inc. ($6,790) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,705.00 | General |
| 11/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,825.00 | General |
| 10/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,155.00 | General |
| 10/02/2023 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $9,150.00 | General |
| 09/01/2023 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $6,675.00 | General |
| 09/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,055.00 | General |
| 08/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,275.00 | General |
| 07/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,890.00 | General |
| 06/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,610.00 | General |
| 05/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,575.00 | General |
| 04/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,700.00 | General |
| 03/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,525.00 | General |
| 02/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,710.00 | General |
| 01/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,510.00 | General |
| 12/16/2022 | Penumbra, Inc. | RUBY Coil (Device) | Food and Beverage | Cash or cash equivalent | $7.31 | General |
| Category: Peripheral Intervention | ||||||
| 12/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/04/2022 | Penumbra, Inc. | RUBY Coil (Device) | Food and Beverage | Cash or cash equivalent | $10.69 | General |
| Category: Peripheral Intervention | ||||||
| 11/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| 10/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| 09/30/2022 | Penumbra, Inc. | RUBY Coil (Device) | Food and Beverage | Cash or cash equivalent | $15.15 | General |
| Category: Peripheral Intervention | ||||||
| 09/08/2022 | Penumbra, Inc. | RUBY Coil (Device) | Food and Beverage | Cash or cash equivalent | $142.69 | General |
| Category: Peripheral Intervention | ||||||
| 09/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $225.00 | General |
| 08/25/2022 | Penumbra, Inc. | RUBY Coil (Device) | Food and Beverage | Cash or cash equivalent | $3.28 | General |
| Category: Peripheral Intervention | ||||||
| 07/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 11/24/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $1,615.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,817 | 1,860 | $675,635 | $93,932 |
| 2022 | 33 | 1,957 | 2,031 | $536,822 | $95,700 |
| 2021 | 26 | 3,040 | 9,425 | $982,229 | $131,647 |
| 2020 | 25 | 2,758 | 8,909 | $804,631 | $109,056 |
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 331 | 337 | $207,255 | $25,532 | 12.3% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 349 | 356 | $117,480 | $16,464 | 14.0% |
| 72197 | Mri scan of pelvis before and after contrast | Office | 2023 | 113 | 115 | $66,125 | $10,447 | 15.8% |
| 74183 | Mri scan of abdomen before and after contrast | Office | 2023 | 104 | 106 | $59,890 | $9,444 | 15.8% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 149 | 150 | $45,750 | $6,628 | 14.5% |
| 72195 | Mri scan of pelvis without contrast | Office | 2023 | 95 | 95 | $37,050 | $5,803 | 15.7% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 47 | 47 | $27,025 | $3,425 | 12.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 131 | 140 | $22,400 | $3,278 | 14.6% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 88 | 93 | $19,530 | $2,701 | 13.8% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 26 | 26 | $17,810 | $2,082 | 11.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 165 | 172 | $10,320 | $1,542 | 14.9% |
| 71275 | Ct scan of blood vessels of chest with contrast | Office | 2023 | 19 | 19 | $9,120 | $1,439 | 15.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 35 | 36 | $7,200 | $1,038 | 14.4% |
| 74170 | Ct scan of abdomen before and after contrast | Office | 2023 | 15 | 15 | $5,475 | $873.30 | 16.0% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 18 | 18 | $4,320 | $606.42 | 14.0% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 16 | 16 | $3,200 | $468.32 | 14.6% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 13 | 13 | $3,770 | $429.91 | 11.4% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 20 | 21 | $2,730 | $388.71 | 14.2% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 16 | 16 | $2,800 | $386.88 | 13.8% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 12 | 13 | $2,210 | $322.27 | 14.6% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 11 | 11 | $1,595 | $227.70 | 14.3% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 17 | 17 | $1,020 | $160.14 | 15.7% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 16 | 16 | $960.00 | $152.10 | 15.8% |
| 73552 | X-ray of thigh bone, minimum 2 views | Office | 2023 | 11 | 12 | $600.00 | $92.54 | 15.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2022 | 204 | 209 | $102,828 | $15,213 | 14.8% |
About Dr. Firas Ahmed, MD
Dr. Firas Ahmed, MD is a Diagnostic Radiology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2011. The National Provider Identifier (NPI) number assigned to this provider is 1427341551.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Firas Ahmed, MD has received a total of $109,315 in payments from pharmaceutical and medical device companies, with $84,360 received in 2023. These payments were reported across 60 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($107,125).
As a Medicare-enrolled provider, Ahmed has provided services to 9,572 Medicare beneficiaries, totaling 22,225 services with total Medicare billing of $430,335. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location New York, NY
- Active Since 05/23/2011
- Last Updated 03/29/2017
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1427341551
Products in Payments
- KEYTRUDA (Biological) $6,833
- SAMSCA (Drug) $6,768
- WELIREG (Drug) $3,598
- RUBY Coil (Device) $179.12
- JYNARQUE (Drug) $21.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in New York
Thomas Sos, Md, MD
Diagnostic Radiology — Payments: $4.6M
Martin Prince, Md, Phd, Facr, MD, PHD, FACR
Diagnostic Radiology — Payments: $2.0M
Dr. Lawrence Tanenbaum, M.d, M.D
Diagnostic Radiology — Payments: $1.5M
Dr. Peter Nelson, M.d, M.D
Diagnostic Radiology — Payments: $943,291
Sherelle Laifer-Narin, Md, MD
Diagnostic Radiology — Payments: $695,487
Marc Brown, Md, MD
Diagnostic Radiology — Payments: $586,273